External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ASCAT 2023

-
Coming soon
09:00 AM
Duration 2hrs London, United Kingdom
Trials in progress: the randomized, double-blind, placebo-controlled phase 1b crosswalk-a and phase 2a crosswalk-c trials – crovalimab for the treatment and prevention of vaso-occlusive episodes in sickle cell disease
Marco Aurélio Salvino

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar